Capricor Therapeutics Statistics
Total Valuation
CAPR has a market cap or net worth of $1.82 billion. The enterprise value is $1.51 billion.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CAPR has 57.51 million shares outstanding. The number of shares has increased by 31.97% in one year.
| Current Share Class | 57.51M |
| Shares Outstanding | 57.51M |
| Shares Change (YoY) | +31.97% |
| Shares Change (QoQ) | +6.86% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 44.86% |
| Float | 48.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.93 |
| P/TBV Ratio | 5.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.01, with a Debt / Equity ratio of 0.05.
| Current Ratio | 9.01 |
| Quick Ratio | 8.88 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -35.51 |
Financial Efficiency
Return on equity (ROE) is -46.56% and return on invested capital (ROIC) is -28.93%.
| Return on Equity (ROE) | -46.56% |
| Return on Assets (ROA) | -25.68% |
| Return on Invested Capital (ROIC) | -28.93% |
| Return on Capital Employed (ROCE) | -33.78% |
| Weighted Average Cost of Capital (WACC) | 6.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$454,736 |
| Employee Count | 231 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CAPR has paid $1,600 in taxes.
| Income Tax | 1,600 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +244.23% in the last 52 weeks. The beta is 0.48, so CAPR's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +244.23% |
| 50-Day Moving Average | 27.72 |
| 200-Day Moving Average | 15.74 |
| Relative Strength Index (RSI) | 57.34 |
| Average Volume (20 Days) | 1,359,548 |
Short Selling Information
The latest short interest is 7.34 million, so 12.76% of the outstanding shares have been sold short.
| Short Interest | 7.34M |
| Short Previous Month | 6.89M |
| Short % of Shares Out | 12.76% |
| Short % of Float | 15.12% |
| Short Ratio (days to cover) | 4.79 |
Income Statement
| Revenue | n/a |
| Gross Profit | -84.45M |
| Operating Income | -108.14M |
| Pretax Income | -105.04M |
| Net Income | -105.04M |
| EBITDA | -106.25M |
| EBIT | -108.14M |
| Earnings Per Share (EPS) | -$2.26 |
Full Income StatementBalance Sheet
The company has $318.13 million in cash and $14.52 million in debt, with a net cash position of $303.61 million or $5.28 per share.
| Cash & Cash Equivalents | 318.13M |
| Total Debt | 14.52M |
| Net Cash | 303.61M |
| Net Cash Per Share | $5.28 |
| Equity (Book Value) | 305.79M |
| Book Value Per Share | 5.33 |
| Working Capital | 287.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$69.81 million and capital expenditures -$11.72 million, giving a free cash flow of -$81.54 million.
| Operating Cash Flow | -69.81M |
| Capital Expenditures | -11.72M |
| Depreciation & Amortization | 1.89M |
| Net Borrowing | n/a |
| Free Cash Flow | -81.54M |
| FCF Per Share | -$1.42 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CAPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.97% |
| Shareholder Yield | -31.97% |
| Earnings Yield | -5.78% |
| FCF Yield | -4.49% |
Analyst Forecast
The average price target for CAPR is $44.63, which is 41.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.63 |
| Price Target Difference | 41.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 5, 2019. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 5, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
